KFDA to suspend production of Galamin, etc.

The KFDA said it discovered some defects in Kuhnpoong Pharm's manufacturing facilities for injectables with the mixing problems of foreign materials as a results of its special inspection and called for the competent authorities to seal their nine items including Galamin inj. and Mecamol inj.

Kuhnpoong Pharm said on October 23 that it would suspend the marketing and production of nine items ...